REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Alfa C Ltda (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Laboratorio Clinico Alfa C Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Laboratorio Clinico Alfa C Ltda is based in Ecuador, with the head office in Guayaquil. The company operates in the Medical and Diagnostic Laboratories industry. It was first established on July 13, 1977. It currently has a total number of 4 (2021) employees. In 2021, the company reported a net sales revenue increase of 85.97%. Over the same period, its total assets grew by 18%. The enterprise’s net profit margin increased by 1.42% in 2021.

Headquarters
L.Urdaneta 1702, Ines Maria Bldg. , Floor 1
Guayaquil; Guayas;

Contact Details: Purchase the Laboratorio Clinico Alfa C Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Clinico Alfa C Ltda report to view the information.
Outstanding Shares:
Purchase the Laboratorio Clinico Alfa C Ltda report to view the information.
Registered Capital:
Purchase the Laboratorio Clinico Alfa C Ltda report to view the information.
Incorporation Date:
July 13, 1977
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
99.75%
Purchase this report to view the information.
0.25%
Company Performance
Financial values in the chart are available after Laboratorio Clinico Alfa C Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
85.97%
Total operating revenue
85.97%
Operating profit (EBIT)
113.73%
EBITDA
99.7%
Net Profit (Loss) for the Period
152.34%
Total assets
18%
Total equity
17.68%
Operating Profit Margin (ROS)
0.97%
Net Profit Margin
1.42%
Return on Equity (ROE)
8.01%
Debt to Equity Ratio
-0.12%
Quick Ratio
-0.1%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?